Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Auxora
2. Cm 4620
3. Cm-128
4. Cm-4620
5. Cm128
6. Cm4620
7. N-(5-(6-chloro-2,2-difluorobenzo(d)(1,3)dioxol-5-yl)pyrazin-2-yl)-2-fluoro-6-methylbenzamide
8. Zegocractin
1. Cm-4620
2. 1713240-67-5
3. Zegocractin
4. Cm4620
5. Zegocractin [inn]
6. Chembl4753998
7. 564aw1rr37
8. N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)pyrazin-2-yl]-2-fluoro-6-methylbenzamide
9. Benzamide, N-(5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)-2-pyrazinyl)-2-fluoro-6-methyl-
10. N-(5-(6-chloro-2,2-difluorobenzo(d)(1,3)dioxol-5-yl)pyrazin-2-yl)-2-fluoro-6-methylbenzamide
11. Cm 4620
12. Unii-564aw1rr37
13. Schembl18038390
14. Gtpl10087
15. Cm-4620 [who-dd]
16. Cm 4620 Pound>>cm4620
17. Dtxsid901337267
18. Bcp29536
19. Ex-a1898
20. Bdbm50575336
21. S6834
22. Compound I [wo2016138472a1]
23. Sb18686
24. Ac-35758
25. Bs-15636
26. Hy-101942
27. Cs-0022201
28. C73294
29. N-[5-(6-chloro-2,2-difluoro-1,3-benzodioxol-5-yl)-2-pyrazinyl]-2-fluoro-6-methylbenzamide
| Molecular Weight | 421.8 g/mol |
|---|---|
| Molecular Formula | C19H11ClF3N3O3 |
| XLogP3 | 4.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 3 |
| Exact Mass | 421.0441034 g/mol |
| Monoisotopic Mass | 421.0441034 g/mol |
| Topological Polar Surface Area | 73.3 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 617 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
20
PharmaCompass offers a list of Zegocractin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Zegocractin manufacturer or Zegocractin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zegocractin manufacturer or Zegocractin supplier.
A CM4620 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CM4620, including repackagers and relabelers. The FDA regulates CM4620 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CM4620 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CM4620 supplier is an individual or a company that provides CM4620 active pharmaceutical ingredient (API) or CM4620 finished formulations upon request. The CM4620 suppliers may include CM4620 API manufacturers, exporters, distributors and traders.
CM4620 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CM4620 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right CM4620 GMP manufacturer or CM4620 GMP API supplier for your needs.
A CM4620 CoA (Certificate of Analysis) is a formal document that attests to CM4620's compliance with CM4620 specifications and serves as a tool for batch-level quality control.
CM4620 CoA mostly includes findings from lab analyses of a specific batch. For each CM4620 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CM4620 may be tested according to a variety of international standards, such as European Pharmacopoeia (CM4620 EP), CM4620 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CM4620 USP).